NDC 61703-237-44 - Enalaprilat
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 61703-237
- Requested NDC
- 61703-237-44
- Package NDCs from labels
- 61703-237-44, 61703-237-16
- Manufacturer
- Mayne Pharma (USA) Inc.
- Effective date
- 2007-03-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Enalaprilat - Mayne Pharma (USA) Inc. | Mayne Pharma (USA) Inc. | 2007-03-16 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61703-237-16 | Enalaprilat | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 1 | |
| 61703-237-44 | Enalaprilat | 1 mL in 1 VIAL | INJECTION, SOLUTION | 1 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| enalaprilat | ACTIVE INGREDIENT | GV0O7ES0R3 | ENALAPRILAT (ENALAPRILAT) INJECTION, SOLUTION [MAYNE PHARMA (USA) INC.] | 1 | |
| enalaprilat | ACTIVE MOIETY | GV0O7ES0R3 | ENALAPRILAT (ENALAPRILAT) INJECTION, SOLUTION [MAYNE PHARMA (USA) INC.] | 1 | |
| benzyl alcohol | INACTIVE INGREDIENT | LKG8494WBH | ENALAPRILAT (ENALAPRILAT) INJECTION, SOLUTION [MAYNE PHARMA (USA) INC.] | 1 | |
| sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | ENALAPRILAT (ENALAPRILAT) INJECTION, SOLUTION [MAYNE PHARMA (USA) INC.] | 1 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | ENALAPRILAT (ENALAPRILAT) INJECTION, SOLUTION [MAYNE PHARMA (USA) INC.] | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | ENALAPRILAT (ENALAPRILAT) INJECTION, SOLUTION [MAYNE PHARMA (USA) INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Enalaprilat | ENALAPRILAT | Dr. Reddys Laboratories Inc | 5d398da1-020c-ccb1-a775-ce8e0b29d621 | 2024-06-07 | Boxed warning, Warnings, Adverse reactions | 1729205 |
| Enalaprilat | ENALAPRILAT | Hikma Pharmaceuticals USA Inc. | eabae489-e254-4987-ab90-7cda20a6f856 | 2024-01-04 | Boxed warning, Warnings, Adverse reactions | 1729205 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.